10.81
price down icon2.79%   -0.31
 
loading
Fibrogen Inc stock is traded at $10.81, with a volume of 9,865. It is down -2.79% in the last 24 hours and down -12.19% over the past month. FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
See More
Previous Close:
$11.12
Open:
$11.06
24h Volume:
9,865
Relative Volume:
0.24
Market Cap:
$43.71M
Revenue:
$147.75M
Net Income/Loss:
$-284.23M
P/E Ratio:
-3.6894
EPS:
-2.93
Net Cash Flow:
$-317.54M
1W Performance:
-3.05%
1M Performance:
-12.19%
6M Performance:
+32.84%
1Y Performance:
+44.71%
1-Day Range:
Value
$10.81
$11.21
1-Week Range:
Value
$10.59
$11.65
52-Week Range:
Value
$4.50
$21.94

Fibrogen Inc Stock (FGEN) Company Profile

Name
Name
Fibrogen Inc
Name
Phone
415-978-1200
Name
Address
350 BAY STREET, SAN FRANCISCO, CA
Name
Employee
225
Name
Twitter
@FibroGenInc
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
FGEN's Discussions on Twitter

Compare FGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FGEN
Fibrogen Inc
10.81 44.97M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.39 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.48 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.91 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
836.39 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.29 34.67B 398.11M -1.03B -868.57M -5.7032

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-08-23 Downgrade BofA Securities Neutral → Underperform
Jun-26-23 Downgrade BofA Securities Buy → Neutral
Jun-26-23 Downgrade Raymond James Outperform → Mkt Perform
Jun-26-23 Downgrade Stifel Buy → Hold
Jun-26-23 Downgrade William Blair Outperform → Mkt Perform
Jun-02-23 Upgrade Stifel Hold → Buy
Jan-31-23 Upgrade William Blair Mkt Perform → Outperform
Jan-26-23 Upgrade Raymond James Mkt Perform → Outperform
Jan-05-23 Upgrade BofA Securities Neutral → Buy
Sep-22-21 Downgrade Goldman Neutral → Sell
Aug-20-21 Upgrade Raymond James Underperform → Mkt Perform
Jul-16-21 Downgrade BofA Securities Buy → Neutral
Jul-16-21 Downgrade Stifel Buy → Hold
Apr-07-21 Downgrade H.C. Wainwright Buy → Neutral
Apr-07-21 Downgrade Mizuho Buy → Neutral
Mar-31-21 Upgrade BofA Securities Neutral → Buy
Mar-02-21 Downgrade Jefferies Buy → Hold
Feb-01-21 Initiated H.C. Wainwright Buy
Oct-26-20 Initiated Raymond James Underperform
Jul-10-20 Resumed Stifel Buy
May-01-20 Initiated Cowen Market Perform
Apr-27-20 Initiated BofA/Merrill Neutral
May-29-19 Resumed Goldman Neutral
May-10-19 Downgrade William Blair Outperform → Mkt Perform
Apr-12-19 Initiated Piper Jaffray Neutral
Feb-11-19 Resumed Stifel Buy
Dec-19-18 Upgrade Citigroup Neutral → Buy
Aug-08-17 Reiterated Leerink Partners Outperform
Aug-08-17 Reiterated Stifel Buy
Jul-21-17 Downgrade Goldman Buy → Neutral
Jul-11-17 Initiated Jefferies Buy
Feb-11-16 Upgrade Credit Suisse Neutral → Outperform
Jan-21-16 Initiated Credit Suisse Neutral
Dec-04-15 Initiated Citigroup Buy
Sep-23-15 Initiated Lake Street Hold
Jul-29-15 Initiated Citigroup Buy
Jul-20-15 Upgrade Goldman Neutral → Buy
Dec-09-14 Initiated Stifel Buy
View All

Fibrogen Inc Stock (FGEN) Latest News

pulisher
12:52 PM

Technical signs of recovery in FibroGen Inc.Inflation Watch & Real-Time Chart Pattern Alerts - newser.com

12:52 PM
pulisher
Oct 28, 2025

What does recent volatility data suggest for FibroGen Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Should you hold or exit FibroGen Inc. nowDividend Hike & Low Risk Investment Opportunities - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Forecasting FibroGen Inc. price range with options dataWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is FibroGen Inc. reversing from oversold territoryQuarterly Growth Report & Fast Gain Swing Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Why FibroGen Inc. stock attracts global investorsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is FibroGen Inc. stock attractive for hedge fundsJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What to expect from FibroGen Inc. in the next 30 daysQuarterly Market Review & Momentum Based Trading Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can FibroGen Inc. (1FG0) stock reach $200 price targetWall Street Watch & Verified Technical Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Chart based exit strategy for FibroGen Inc.July 2025 Closing Moves & Momentum Based Trading Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can FibroGen Inc. stock sustain institutional interestJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can FibroGen Inc. stock outperform in 2025 bull market2025 Stock Rankings & Smart Money Movement Tracker - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

How to integrate FibroGen Inc. into portfolio analysis toolsWeekly Trade Summary & AI Powered Buy and Sell Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Building trade automation scripts for FibroGen Inc.July 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is FibroGen Inc. (1FG0) stock expanding market penetrationEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to read the order book for FibroGen Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What hedge fund activity signals for FibroGen Inc. stockGap Up & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 27, 2025

Fibrogen Inc Stock (FGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.41
price down icon 2.28%
$91.65
price down icon 1.54%
$29.13
price up icon 0.34%
$105.03
price down icon 0.96%
biotechnology ONC
$316.85
price up icon 0.45%
$165.29
price up icon 0.77%
Cap:     |  Volume (24h):